EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

VCAM-1+ Mesenchymal Stem/Stromal Cells Reveal Preferable Efficacy Upon an Experimental Autoimmune Encephalomyelitis Mouse Model of Multiple Sclerosis Over the VCAM-1− Counterpart

Haixia Liu, Dongqing Cui, Shasha Huangfu, Xiaojun Wang, Xiao Yu, Hui Yang, Xiaolei Zheng, Yan Li, Jianzhong Bi, Leisheng Zhang, Ping Wang

Neurochemical Research · 2025

DOI: 10.1007/s11064-024-04267-w ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neurochemical Research, 2025. Verfasst von Haixia Liu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, The Second Hospital of Shandong University, 247 Beiyuan Road, Jinan, China. Hauptthemen laut MEDLINE: Vascular Cell Adhesion Molecule-1, Encephalomyelitis, Autoimmune, Experimental, Mesenchymal Stem Cells, Mesenchymal Stem Cell Transplantation. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Jinan Clinical Medical Science and Technology Innovation Program, Cultivation Fund of the Second Hospital of Shandong University, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite the considerable progress in mesenchymal stem/stromal cells (MSCs)-based novel intervention of multiple sclerosis (MS), yet the disease-modifying effect of VCAM-1- MSCs and novel VCAM-1+ counterpart is largely obscure. In this study, we took advantage of the EAE mouse model and VCAM-1+ human umbilical cord-derived MSCs (hUC-MSCs) for the evaluation of the therapeutic effect of systematic MSCs infusion. On the one hand, we compared the protective effect of VCAM-1- and VCAM-1+ hUC-MSCs against the clinical symptoms, demyelination, active glia cells and neuroinflammation in EAE mice by conducting multifaceted detections upon spinal cord and brain tissues. On the other hand, we conducted RNA-sequencing (RNA-SEQ) and multidimensional bioinformatics analyses for the evaluation of the transcriptomic features of spinal cord tissue in EAE mice after systematic hUC-MSCs infusion. Compared to those with VCAM-1- hUC-MSCs injection, VCAM-1+ mice showed further remission in clinical manifestations, and in particular, the inflammatory infiltration and active glial cells. Mice in all groups revealed conservations in overall gene expression profiling and somatic mutation spectrum. The differentially expressed genes (DEGs) between EAE mice and those with hUC-MSCs infusion were mainly involved in neuroinflammation and inflammatory response. Our findings indicated the feasibility of VCAM-1+ hUC-MSCs for multiple sclerosis treatment, which would supply new references for the development of novel VCAM-1+ MSCs-based cytotherapy in future.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vascular Cell Adhesion Molecule-1Encephalomyelitis, Autoimmune, ExperimentalMesenchymal Stem CellsMesenchymal Stem Cell TransplantationMultiple SclerosisMice, Inbred C57BLAnimalsMiceFemaleHumansSpinal Cord

Stichwörter der Autor:innen

Experimental autoimmune encephalomyelitis (EAE)Mesenchymal stem/stromal cells (MSCs)Multiple sclerosis (MS)NeuroinflammationTranscriptomic signaturesVCAM-1

Substanzen

Vascular Cell Adhesion Molecule-1

Autor:innen und Institutionen

  • Department of Neurology, The Second Hospital of Shandong University, 247 Beiyuan Road, Jinan, China.
  • Department of Neurology, Weihai Municipal Hospital, Weihai, China.
  • Universal Biomedical Research Institute, Zibo, China.
  • Science and Technology Innovation Center, Shandong Provincial Key Medical and Health Laboratory of Blood Ecology and Biointelligence, Jinan Key Laboratory of Medical Cell Bioengineering, The Fourth People's Hospital of…
  • National Health Commission (NHC) Key Laboratory of Diagnosis and Therapy of Gastrointestinal Tumor, Gansu Provincial Hospital, 204 Donggang West Road, Lanzhou, China. leisheng_zhang@163.com.
  • Department of Neurology, The Second Hospital of Shandong University, 247 Beiyuan Road, Jinan, China. wping0108@163.com.

Förderung

  • Jinan Clinical Medical Science and Technology Innovation Program
  • Cultivation Fund of the Second Hospital of Shandong University
  • National Natural Science Foundation of China
  • Postdoctoral Program of Natural Science Foundation of Gansu Province
  • Gansu Provincial Hospital Intra-Hospital Research Fund Project
  • The 2022 Master/Doctor/Postdoctoral program of NHC Key Laboratory of Diagnosis and Therapy of Gastrointestinal Tumor
  • General Program of Shandong Province Natural Science Foundation

Zitieren

APA

Liu, H., Cui, D., Huangfu, S., Wang, X., Yu, X., Yang, H., Zheng, X., Li, Y., Bi, J., Zhang, L., & Wang, P. (2025). VCAM-1+ Mesenchymal Stem/Stromal Cells Reveal Preferable Efficacy Upon an Experimental Autoimmune Encephalomyelitis Mouse Model of Multiple Sclerosis Over the VCAM-1− Counterpart. Neurochemical Research. https://doi.org/10.1007/s11064-024-04267-w

Vancouver

Liu H, Cui D, Huangfu S, Wang X, Yu X, Yang H, et al. VCAM-1+ Mesenchymal Stem/Stromal Cells Reveal Preferable Efficacy Upon an Experimental Autoimmune Encephalomyelitis Mouse Model of Multiple Sclerosis Over the VCAM-1− Counterpart. Neurochemical Research. 2025. doi:10.1007/s11064-024-04267-w

BibTeX
@article{Liu2025,
  author = {Liu, Haixia and Cui, Dongqing and Huangfu, Shasha and Wang, Xiaojun and Yu, Xiao and Yang, Hui and Zheng, Xiaolei and Li, Yan and Bi, Jianzhong and Zhang, Leisheng and Wang, Ping},
  title = {VCAM-1+ Mesenchymal Stem/Stromal Cells Reveal Preferable Efficacy Upon an Experimental Autoimmune Encephalomyelitis Mouse Model of Multiple Sclerosis Over the VCAM-1− Counterpart},
  journal = {Neurochemical Research},
  year = {2025},
  doi = {10.1007/s11064-024-04267-w}
}
Kostenlos starten →